- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02981433
Vulvodynia: Identification of Potential Relevant Biomarkers
Activation of the Sphingosine-1-phosphate (S1P) to S1P1 Receptor Subtype (S1PR1) Axis in Patients With Vulvodynia: Identification of Potential Relevant Biomarkers
Vulvodynia is a syndrome of unexplained vulvar pain that is frequently accompanied by physical disabilities, limitation of daily activities (such as sitting and walking), sexual dysfunction and psychologic disability. Originally suggested by McKay, the term "vulvodynia" has also been suggested by the International Society for the Study of Vulvar Disease Task Force to describe any vulvar pain. The incidence and prevalence of vulvodynia have not been well studied. Age distribution for the condition may range from the 20s to the 60s, and it is limited almost exclusively to white women. Obstetric and gynecologic history is usually unremarkable. Risk-taking sexual behavior is rare, and few patients have a history of sexually transmitted diseases. Vulvar pain usually has an acute onset, at times associated with episodes of vaginitis or certain therapeutic procedures of the vulva (cryotherapy or laser therapy). In most cases, vulvodynia becomes a chronic problem lasting months to years. Vulvar pain is frequently described as burning or stinging, or a feeling of rawness or irritation.
Most patients consult several physicians before being diagnosed. Many are treated with multiple topical or systemic medications, with minimal relief. In some cases, inappropriate therapy may even make the symptoms worse. Since physical findings are few and cultures and biopsies are frequently negative, patients may be told that the problem is primarily psychologic, thus invalidating their pain and adding to their distress.
Study Overview
Status
Conditions
Detailed Description
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Missouri
-
Saint Louis, Missouri, United States, 63107
- St. Lukes Doctors South Office building
-
Saint Louis, Missouri, United States, 63117
- 1031 Bellevue office suite 200
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
For patients with vulvodynia-related painwill be offered enrollment into the study. At their visit before treatment begins they will have:
blood drawn ,(about 10ml-two teaspoons) this is research related. The ISSVD (The International Society for the Study of Vulvovaginal Disease) classification and diagnostic criteria for vulvodynia will be used for inclusion in this study.
Vulvodynia - Vulvar pain of at least 3 months' duration,
Descriptors:
- Localized (e.g. vestibulodynia, clitorodynia) or Generalized or Mixed (localized and generalized)
- Provoked (e.g. insertional, contact) or Spontaneous or Mixed (provoked and spontaneous)
- Onset (primary or secondary)
- Temporal pattern (intermittent, persistent, constant, immediate, delayed)
Description
Inclusion Criteria:
- 18-70 years of age
- Vulvar pain of at least 3 months' duration
- Localized (e.g. vestibulodynia, clitorodynia) or Generalized or Mixed
- Provoked or Spontaneous or Mixed Onset
- Temporal pattern
Exclusion Criteria:
- <18 or >70 years of age
- pregnant
- Not able to provide consent
- Patients with active vulvar dystrophies.
Study Plan
How is the study designed?
Design Details
- Observational Models: Case-Only
- Time Perspectives: Prospective
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
S1PR1 elevation
Time Frame: up to one year
|
S1PR1 is elevated in the peripheral blood leukocytes (PBLs) of patients with vulvodyna-related pain.
|
up to one year
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Cherie LeFevre, MD, St. Louis University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 27036
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Vulvodynia
-
University Hospital, GhentCompletedLocalized Provoked VulvodyniaBelgium
-
Oregon Health and Science UniversityMedical Research Foundation, OregonCompleted
-
Meir Medical CenterCompleted
-
McLean Center for Complementary and Alternative...UnknownVulvodynia | Vulvar Vestibulitis | Vulvodynia, Generalized | Vulvar PainUnited States
-
Meir Medical CenterCompletedLocalized Provoked VulvodyniaIsrael
-
Uppsala UniversityCompletedVulvodynia, Generalized | Provoked VestibulodyniaSweden
-
Oregon College of Oriental MedicineOregon Health and Science University; National Vulvodynia Association; Council...CompletedVulvodynia | Vulvar Vestibulitis | Provoked Vestibulodynia | Provoked, Localized VulvodyniaUnited States
-
University of Illinois at ChicagoUniversity of FloridaCompletedVulvodynia | Vulvar Vestibulitis | Vulvodynia, GeneralizedUnited States
-
Colleen StockdaleTerminatedVulvar Pain Symptoms | Vulvodynia (Chronic Vulvar Pain)United States
-
University of TennesseeUniversity of Tennessee Health Science CenterCompleted